Future studies may focus on the characterization of SCD + SOI individuals, as well as on pathological markers such as amyloid, tau, a-synuclein, or underlying cerebrovascular disease that previously have shown associations with self-rated measures (Jylhä et al., 2006). The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.